Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KRISCHER, Jeffrey P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 56

  • Page / 3
Export

Selection :

  • and

Type 1 Diabetes manifested solely by 2-h oral glucose tolerance test criteriaGREENBAUM, Carla J; CUTHBERTSON, David; KRISCHER, Jeffrey P et al.Diabetes (New York, NY). 2001, Vol 50, Num 2, pp 470-476, issn 0012-1797Article

The use of intermediate endpoints in the design of type 1 diabetes prevention trialsKRISCHER, Jeffrey P.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 1919-1924, issn 0012-186X, 6 p.Article

Heterogeneous but standard coding systems for adverse events : Issues in achieving interoperability between apples and orangesRICHESSON, Rachel L; KIN WAH FUNG; KRISCHER, Jeffrey P et al.Contemporary clinical trials. 2008, Vol 29, Num 5, pp 635-645, issn 1551-7144, 11 p.Article

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 DiabetesPING XU; XIAONING QIAN; SCHATZ, Desmond A et al.Diabetes care. 2014, Vol 37, Num 7, pp 1959-1965, issn 0149-5992, 7 p.Article

Male sex increases the risk of autoimmunity but not type 1 DiabetesKRISCHER, Jeffrey P; CUTHBERTSON, David D; GREENBAUM, Carla et al.Diabetes care. 2004, Vol 27, Num 8, pp 1985-1990, issn 0149-5992, 6 p.Article

An Automated Standardized System for Managing Adverse Events in Clinical Research NetworksRICHESSON, Rachel L; MALLOY, Jamie F; PAULUS, Kathleen et al.Drug safety. 2008, Vol 31, Num 10, pp 807-822, issn 0114-5916, 16 p.Article

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsMORAN, Antoinette; BUNDY, Brian; SANDA, Srinath et al.Lancet (British edition). 2013, Vol 381, Num 9881, pp 1905-1915, issn 0140-6736, 11 p.Article

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudySOSENKO, Jay M; SKYLER, Jay S; PALMER, Jerry P et al.Diabetes care. 2011, Vol 34, Num 8, pp 1785-1787, issn 0149-5992, 3 p.Article

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes : The diabetes prevention trial-type 1SOSENKO, Jay M; PALMER, Jerry P; CUTHBERTSON, David et al.Diabetes care. 2007, Vol 30, Num 1, pp 38-42, issn 0149-5992, 5 p.Article

Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetesKRISCHER, Jeffrey P; CUTHBERTSON, David D; LIPING YU et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 1, pp 103-108, issn 0021-972X, 6 p.Article

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical AutoantibodiesLIPING YU; BOULWARE, David C; EISENBARTH, George S et al.Diabetes care. 2012, Vol 35, Num 6, pp 1213-1218, issn 0149-5992, 6 p.Article

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) oral insulin trialVEHIK, Kendra; CUTHBERTSON, David; RUHLIG, Holly et al.Diabetes care. 2011, Vol 34, Num 7, pp 1585-1590, issn 0149-5992, 6 p.Article

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjectsUCHIDA, Kanji; NAKATA, Koh; KEICHO, Naoto et al.Blood. 2009, Vol 113, Num 11, pp 2547-2556, issn 0006-4971, 10 p.Article

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1ORBAN, Tihamer; SOSENKO, Jay M; CUTHBERTSON, David et al.Diabetes care. 2009, Vol 32, Num 12, pp 2269-2274, issn 0149-5992, 6 p.Article

Safety of Purified Isoflavones in Men With Clinically Localized Prostate CancerKUMAR, Nagi B; KRISCHER, Jeffrey P; ALLEN, Kathy et al.Nutrition and cancer. 2007, Vol 59, Num 2, pp 169-175, issn 0163-5581, 7 p.Article

Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1SOSENKO, Jay M; PALMER, Jerry P; CUTHBERTSON, David et al.Diabetes care. 2006, Vol 29, Num 3, pp 643-649, issn 0149-5992, 7 p.Article

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesPAL, Tuya; PERMUTH-WEY, Jenny; WILBANKS, George et al.Cancer. 2005, Vol 104, Num 12, pp 2807-2816, issn 0008-543X, 10 p.Article

Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and YouthVEHIK, Kendra; CUTHBERTSON, David; BOULWARE, David et al.Diabetes care. 2012, Vol 35, Num 9, pp 1821-1825, issn 0149-5992, 5 p.Article

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Lancet (British edition). 2011, Vol 378, Num 9789, pp 412-419, issn 0140-6736, 8 p.Article

Patient-derived Granulocyte/Macrophage Colony-Stimulating Factor Autoantibodies Reproduce Pulmonary Alveolar Proteinosis in Nonhuman PrimatesSAKAGAMI, Takuro; BECK, David; WHITSETT, Jeffrey A et al.American journal of respiratory and critical care medicine. 2010, Vol 182, Num 1, pp 49-61, issn 1073-449X, 13 p.Article

Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in JapanINOUE, Yoshikazu; TRAPNELL, Bruce C; TANAKA, Naohiko et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 7, pp 752-762, issn 1073-449X, 11 p.Article

First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetesCHASE, H. Peter; CUTHBERTSON, David D; DOLAN, Lawrence M et al.The Journal of pediatrics. 2001, Vol 138, Num 2, pp 244-249, issn 0022-3476Article

Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patientsZEIDLER, Adina; RAFFEL, Leslie J; MACLAREN, Noel K et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 10, pp 4957-4962, issn 0021-972XArticle

Effects of health insurance and race on breast carcinoma treatments and outcomesROETZHEIM, Richard G; GONZALEZ, Eduardo C; FERRANTE, Jeanne M et al.Cancer. 2000, Vol 89, Num 11, pp 2202-2213, issn 0008-543XArticle

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsPESCOVITZ, Mark D; GREENBAUM, Carla J; RODRIGUEZ, Henry et al.Diabetes care. 2014, Vol 37, Num 2, pp 453-459, issn 0149-5992, 7 p.Article

  • Page / 3